Background: Non-cystic fibrosis (CF) bronchiectasis has previously been reported to be rare and progressive in children living in western societies. Method: A clinical and radiological review was ...

Background: A study was undertaken to compare the ability of computed tomographic (CT) scores and pulmonary function tests to detect changes in lung disease in children and adults with cystic fibrosis ...

Patients with bronchiectasis face heightened risks of severe exacerbation and mortality after COVID-19 recovery, especially ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Non-Cystic Fibrosis Bronchiectasis (NCFB) lacks FDA-approved drugs. Innovation is accelerating to meet high unmet needs and redefine chronic lung care. NCFB is the definition of an untapped market ...

The impact of bronchiectasis on the severity of COVID-19 infection has been contradictory. Some studies report that ...

Boehringer Ingelheim has breathed life into an American Lung Association campaign, providing support for a new push to ...

Transabdominal ultrasound shows potential as an alternative and cost-effective method for monitoring selected patients with ...

Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic and progressive lung condition that ...

Patients with bronchiectasis and a Pseudomonas aeruginosa infection receiving gremubamab, a bispecific monoclonal antibody, ...

TOPLINE: In the US, children with cystic fibrosis (CF) were significantly less likely to develop food allergies than children without CF. However, boys and children not receiving pancreatic enzyme ...

TUESDAY, June 24, 2025 (HealthDay News) — Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs ...